# Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma

> **NCT03582293** · PHASE3 · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 554 (estimated)

## Conditions studied

- Hematoma, Subdural, Chronic

## Interventions

- **DRUG:** Tranexamic Acid 500Mg Tablet
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03582293
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-19
- **Primary completion:** 2029-04-30
- **Final completion:** 2029-10-30
- **Target enrollment:** 554 (ESTIMATED)
- **Last updated:** 2024-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582293, "Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03582293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*